{"nct_id":"NCT02135692","title":"A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2014-05-29","start_date_type":"ACTUAL","primary_completion_date":"2017-10-05","primary_completion_date_type":"ACTUAL","completion_date":"2017-10-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}